Microendophenotypes of psychiatric disorders: Phenotypes of psychiatric disorders at the level of molecular dynamics, synapses, neurons, and neural circuits

Current Molecular Medicine

Volumn 15, Issue 2, 2015, Pages 111-118

  Kida, S ^a   Kato, T ^b  

^a TOKYO UNIVERSITY OF AGRICULTURE   (Japan)

^b RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

Animal model; Bipolar disorder; Depression; Endophenotype; Microendophenotype; Psychiatric disorder; PTSD; Schizophrenia

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; NERVE PROTEIN;

ARTICLE; BIPOLAR DISORDER; COGNITIVE THERAPY; CONNECTOME; COPY NUMBER VARIATION; DEPRESSION; DIZYGOTIC TWINS; ENDOPHENOTYPE; GENE DELETION; GENETIC ASSOCIATION; GENETIC ENGINEERING; HEREDITY; HUMAN; MENTAL DISEASE; MOLECULAR DYNAMICS; MONOZYGOTIC TWINS; NERVE CELL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PLURIPOTENT STEM CELL; POSITRON EMISSION TOMOGRAPHY; POSTTRAUMATIC STRESS DISORDER; SINGLE NUCLEOTIDE POLYMORPHISM; SYNAPSE; ANIMAL; BRAIN; CHROMOSOME ABERRATION; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MUTATION; NERVE CELL NETWORK; PATHOLOGY; PATHOPHYSIOLOGY; SCHIZOPHRENIA; SYNAPTIC TRANSMISSION;

ANIMALIA;

ANIMALS; BIPOLAR DISORDER; BRAIN; CHROMOSOME ABERRATIONS; DEPRESSION; DISEASE MODELS, ANIMAL; ENDOPHENOTYPES; GENE EXPRESSION REGULATION; HUMANS; MUTATION; NERVE NET; NERVE TISSUE PROTEINS; NEURONS; SCHIZOPHRENIA; STRESS DISORDERS, POST-TRAUMATIC; SYNAPSES; SYNAPTIC TRANSMISSION;

EID: 84930980437     PISSN: 15665240     EISSN: 18755666     Source Type: Journal    
DOI: 10.2174/1566524015666150303002128     Document Type: Article

References (65)

1. Sullivan PF, Daly MJ, O'Donovan M. Genetic architectures of psychiatric disorders: the emerging picture and its implications. Nat Rev Genet 2012; 13: 537-51.
2. Craddock N, Sklar P. Genetics of bipolar disorder. Lancet 2013; 381: 1654-62.
3. Doherty JL, O'Donovan MC, Owen MJ. Recent genomic advances in schizophrenia. Clin Genet 2012; 81: 103-9.
4. Malhotra D, Sebat J. CNVs: harbingers of a rare variant revolution in psychiatric genetics. Cell 2012; 148: 1223-41.
5. Ronemus M, Iossifov I, Levy D, Wigler M. The role of de novo mutations in the genetics of autism spectrum disorders. Nat Rev Genet 2014; 15: 133-41.
6. Xu B, Ionita-Laza I, Roos JL, et al. De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia. Nat Genet 2012; 44: 1365-9.
7. Cross-Disorder Group of the Psychiatric Genomics Consortium; Genetic Risk Outcome of Psychosis (GROUP) Consortium. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 2013; 381: 1371-9.
8. Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003; 160: 636-45.
9. Greenwood TA, Braff DL, Light GA, et al. Initial heritability analyses of endophenotypic measures for schizophrenia: the consortium on the genetics of schizophrenia. Arch Gen Psychiatry 2007; 64: 1242-50.
10. Papaleo F, Lipska BK, Weinberger DR. Mouse models of genetic effects on cognition: relevance to schizophrenia. Neuropharmacology 2012; 62: 1204-20.
11. Hikida T, Jaaro-Peled H, Seshadri S, et al. Dominantnegative DISC1 transgenic mice display schizophreniaassociated phenotypes detected by measures translatable to humans. Proc Natl Acad Sci U S A 2007; 104: 14501-6.
12. Li W, Zhou Y, Jentsch JD, et al. Specific developmental disruption of disrupted-in-schizophrenia-1 function results in schizophrenia-related phenotypes in mice. Proc Natl Acad Sci U S A 2007; 104: 18280-5.
13. Shen S, Lang B, Nakamoto C, et al. Schizophrenia-related neural and behavioral phenotypes in transgenic mice expressing truncated Disc1. J Neurosci 2008; 28: 10893-904.
14. Clapcote SJ, Lipina TV, Millar JK, et al. Behavioral phenotypes of Disc1 missense mutations in mice. Neuron 2007; 54: 387-402.
15. Niwa M, Kamiya A, Murai R, et al. Knockdown of DISC1 by in utero gene transfer disturbs postnatal dopaminergic maturation in the frontal cortex and leads to adult behavioral deficits. Neuron 2010; 65: 480-9.
16. Hashimoto T, Volk DW, Eggan SM, et al. Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J Neurosci 2003; 23: 6315-26.
17. Glantz LA, Lewis DA. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry 2000; 57: 65-73.
18. Stark KL, Xu B, Bagchi A, et al. Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model. Nat Genet 2008; 40: 751-60.
19. Booij J, van Amelsvoort T. Imaging as tool to investigate psychoses and antipsychotics. Handb Exp Pharmacol 2012; 212: 299-337.
20. Veltman DJ, Ruhe HG, Booij J. Investigating serotonergic function using positron emission tomography: overview and recent findings. Curr Pharm 2010; 16: 1979-89.
21. Tokita K, Yamaji T, Hashimoto K. Roles of glutamate signaling in preclinical and/or mechanistic models of depression. Pharmacol Biochem Behav 2012; 100: 688-704.
22. Hashimoto K. The role of glutamate on the action of antidepressants. Prog Neuropsychopharmacol Biol Psychiatry 2011; 35: 1558-68.
23. McEwen BS. Stress, sex, and neural adaptation to a changing environment: mechanisms of neuronal remodeling. Ann N Y Acad Sci 2010; 1204 Suppl: E38-59.
24. Pittenger C, Duman RS. Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology 2008; 33: 88-109.
25. Fuchs E, Flugge G, Czeh B. Remodeling of neuronal networks by stress. Front Biosci 2006; 11: 2746-58.
26. Krishnan V, Han MH, Graham DL, et al. Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell 2007; 131: 391-404.
27. Kang HJ, Voleti B, Hajszan T, et al. Decreased expression of synapse-related genes and loss of synapses in major depressive disorder. Nat Med 2012; 18: 1413-7.
28. Quiroz JA, Gray NA, Kato T, Manji HK. Mitochondrially mediated plasticity in the pathophysiology and treatment of bipolar disorder. Neuropsychopharmacology 2008; 33: 2551-65.
29. Kato T. Molecular neurobiology of bipolar disorder: a disease of 'mood-stabilizing neurons'? Trends Neurosci 2008; 31: 495-503.
30. Bora E, Fornito A, Yucel M, Pantelis C. Voxelwise metaanalysis of gray matter abnormalities in bipolar disorder. Biol Psychiatry 2010; 67: 1097-105.
31. LeDoux JE. Emotion circuits in the brain. Annu Rev Neurosci 2000; 23: 155-84.
32. Phelps EA, LeDoux JE. Contributions of the amygdala to emotion processing: from animal models to human behavior. Neuron 2005; 48: 175-87.
33. Delgado MR, Nearing KI, Ledoux JE, Phelps EA. Neural circuitry underlying the regulation of conditioned fear and its relation to extinction. Neuron 2008; 59: 829-38.
34. Fanselow MS. Conditioned and unconditional components of post-shock freezing. Pavlov J Biol Sci 1980; 15: 177-82.
35. Kim JJ, Fanselow MS. Modality-specific retrograde amnesia of fear. Science 1992; 256: 675-7.
36. Schiller D, Monfils MH, Raio CM, Johnson DC, Ledoux JE, Phelps EA. Preventing the return of fear in humans using reconsolidation update mechanisms. Nature 2010; 463: 49-53.
37. Davis HP, Squire LR. Protein synthesis and memory. Psychol Bull 1984; 96: 518-59.
38. Silva AJ, Kogan JH, Frankland PW, Kida S. CREB and memory. Annu Rev Neurosci 1998; 21: 127-48.
39. Abel T, Nguye PV, Barad M, Deuel TA, Kandel ER, Bourtchouladze R. Genetic demonstration of a role for PKA in the late phase of LTP and in hippocampus-based longterm memory. Cell 1997; 88: 615-26.
40. Kida S, Josselyn SA, Pena de Ortiz S, et al. CREB required for the stability of new and reactivated fear memories. Nat Neurosci 2002; 5: 348-55.
41. Nader K, Schafe GE, Le Doux JE. Fear memories require protein synthesis in the amygdala for reconsolidation after retrieval. Nature 2000; 406: 722-6.
42. Nader K, Schafe GE, Le Doux JE. The labile nature of consolidation theory. Nat Rev Neurosci 2000; 1: 216-9.
43. Suzuki A, Josselyn S, Frankland P, Masushige S, Silva A, Kida S. Memory reconsolidation and extinction have distinct temporal and biochemical signatures. J Neurosci 2004; 24: 4787-95.
44. Myers KM, Davis M. Behavioral and neural analysis of extinction. Neuron 2002; 36: 567-84.
45. Rauch SL, Shin LM, Phelps EA. Neurocircuitry models of posttraumatic stress disorder and extinction: human neuroimaging research--past, present, and future. Biol Psychiatry 2006; 60: 376-82.
46. Debiec J, LeDoux JE. Noradrenergic signaling in the amygdala contributes to the reconsolidation of fear memory: treatment implications for PTSD. Ann N Y Acad Sci 2006; 1071: 521-4.
47. Brunet A, Orr SP, Tremblay J, Robertson K, Nader K, Pitman RK. Effect of post-retrieval propranolol on psychophysiologic responding during subsequent script-driven traumatic imagery in post-traumatic stress disorder. J Psychiatr Res 2008; 42: 503-6.
48. Richardson R, Ledgerwood L, Cranney J. Facilitation of fear extinction by D-cycloserine: theoretical and clinical implications. Learn Mem 2004; 11: 510-6.
49. Davis M, Ressler K, Rothbaum BO, Richardson R. Effects of D-cycloserine on extinction: translation from preclinical to clinical work. Biol Psychiatry 2006; 60: 369-75.
50. Norberg MM, Krystal JH, Tolin DF. A meta-analysis of Dcycloserine and the facilitation of fear extinction and exposure therapy. Biol Psychiatry 2008; 63: 1118-26.
51. Baum M. Spontaneous recovery from the effects of flooding (exposure) in animals. Behav Res Ther 1988; 26: 185-6.
52. Monfils MH, Cowansage KK, Klann E, LeDoux JE. Extinction-reconsolidation boundaries: key to persistent attenuation of fear memories. Science 2009; 324: 951-5.
53. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-76.
54. Bundo M, Toyoshima M, Okada Y, et al. Increased L1 Retrotransposition in the Neuronal Genome in Schizophrenia. Neuron 2014; 81: 306-13.
55. Chiang CH, Su Y, Wen Z, et al. Integration-free induced pluripotent stem cells derived from schizophrenia patients with a DISC1 mutation. Mol Psychiatry 2011; 16: 358-60.
56. Eiraku M, Watanabe K, Matsuo-Takasaki M, et al. Selforganized formation of polarized cortical tissues from ESCs and its active manipulation by extrinsic signals. Cell Stem Cell 2008; 3: 519-32.
57. Suga H, Kadoshima T, Minaguchi M, et al. Self-formation of functional adenohypophysis in three-dimensional culture. Nature 2011; 480: 57-62.
58. Lancaster MA, Renner M, Martin CA, et al. Cerebral organoids model human brain development and microcephaly. Nature 2013; 501: 373-9.
59. Paylor R, Glaser B, Mupo A, et al. Tbx1 haploinsufficiency is linked to behavioral disorders in mice and humans: implications for 22q11 deletion syndrome. Proc Natl Acad Sci U S A 2006; 103: 7729-34.
60. Paylor R, McIlwain KL, McAninch R, et al. Mice deleted for the DiGeorge/velocardiofacial syndrome region show abnormal sensorimotor gating and learning and memory impairments. Hum Mol Genet 2001; 10: 2645-50.
61. Long JM, Laporte P, Merscher S, et al. Behavior of mice with mutations in the conserved region deleted in velocardiofacial/DiGeorge syndrome. Neurogenetics 2006; 7: 247-57.
62. Sigurdsson T, Stark KL, Karayiorgou M, Gogos JA, Gordon JA. Impaired hippocampal-prefrontal synchrony in a genetic mouse model of schizophrenia. Nature 2010; 464: 763-7.
63. Ellegood J, Markx S, Lerch JP, et al. Neuroanatomical phenotypes in a mouse model of the 22q11.2 microdeletion. Mol Psychiatry 2014; 19: 99-107.
64. Fejgin K, Nielsen J, Birknow MR, et al. A Mouse Model that Recapitulates Cardinal Features of the 15q13.3 Microdeletion Syndrome Including Schizophrenia-and Epilepsy-Related Alterations. Biol Psychiatry 2014; 76: 128-37.
65. Horev G, Ellegood J, Lerch JP, et al. Dosage-dependent phenotypes in models of 16p11.2 lesions found in autism. Proc Natl Acad Sci U S A 2011; 108: 17076-81